Company: TAK
Filing Date: 2025-06-12
Form Type: 6-K
Source: 0001395064-25-000080
Chunk: 1

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-06-12
Form: 6-K
Chunk 1
---
1) Status of repurchase pursuant to a resolution approved by a General Meeting of Shareholders
Not applicable

(2) Status of repurchase pursuant to a resolution approved by a meeting of the Board of Directors

|                                                                       |     |                           |     |   |     |            |                  |     | As of May 31, 2025 |
|:----------------------------------------------------------------------|:----|--------------------------:|:----|:--|:----|-----------:|-----------------:|:----|-------------------:|
|                                                                       |     | Number of shares (shares) |     |   |     |            | Total repurchase 
     amount (JPY) |     |                    |
| Status of the resolution of the Board of Directors (January 30, 2025) 
 (Period of repurchase: from February 17, 2025 to May 31, 2025)        |     |                28,500,000 |     |   |     |            |  100,000,000,000 |     |                    |
| Repurchases during this reporting month (Date of repurchase)          |     |                     -Date |     |   |     |            |                  |     |                    |
| —                                                                     |     |                           |     | — |     |          — |                  |     |                    |
| Total                                                                 |     |                         — |     |   |     |          — |                  |     |                  — |
| Aggregate shares repurchased as of the end of this reporting month    |     |                           |     |   |     | 23,367,100 |                  |     |     99,955,865,500 |
| Progress of share repurchase (%)                                      |     |                     81.99 |     |   |     |            |            99.96 |     |                    |

(Notes) 1. The period of repurchase is based on a trade date, while the date of repurchase is based on the settlement date.

2. It was resolved at the above meeting of the Board of Directors that the method of acquisition shall be open-market repurchase through a trust bank.

3. The acquisition of shares based on the above resolution of the Board of Directors was completed on April 23, 2025 (settlement date basis).

2. Status of disposition

Not applicable

3. Status of treasury shares held

|                                      |     |                           |     | As of May 31, 2025 |
|